Skip to main content



) -- Shares of

Omeros Corporation



) were gapping down Wednesday morning with an open price 16.2% lower than Tuesday's closing price. The stock closed at $13.25 Tuesday and opened today's trading at $11.10.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

The average volume for Omeros has been 176,600 shares per day over the past 30 days. Omeros has a market cap of $297.3 million and is part of the

health care

sector and

TheStreet Recommends


industry. Shares are up 235.2% year to date as of the close of trading on Tuesday.

Omeros Corporation, a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing products targeting inflammation, coagulopathies, and disorders of the central nervous system.

TheStreet Ratings rates Omeros as a


. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income and feeble growth in its earnings per share. You can view the full

Omeros Ratings Report


Get more investment ideas from our

investment research center